CRISTINA LAGATOLLA

University of Trieste

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Microbiology Microbiology professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (7)

Year:

2025

Year:

2024

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Collaborators (8)

Claudia Mauri

University College London

UNITED KINGDOM

View details

M. Cristina Martins

Invited Assistant Professor

Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar

PORTUGAL

View details

Gianluca Morroni

RTD-A (assistant professor)

ITALY

View details

Gianluca Turco

Associate Professor

University of Trieste

ITALY

View details

Gianfranco Sanson

University of Trieste

ITALY

View details

lory saveria croce'

Associate Professor

Università degli Studi di Torino

ITALY

View details

Mauro Giuffrè

University of Trieste

ITALY

View details

Roberto Luzzati

Associate Professor

University of Trieste

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

CRISTINA LAGATOLLA

Research Interests

Explore related searches

Contact this professor

Articles (7)

Electrospun Collagen-Coated Nanofiber Membranes Functionalized with Silver Nanoparticles for Advanced Wound Healing Applications

Vascular Graft Impregnation with a Fosfomycin/Oritavancin Combination to Prevent Early Infection

Aspirin and Infection: A Narrative Review

Correction: Morroni et al. Antimicrobial Activity of Aztreonam in Combination with Old and New β-Lactamase Inhibitors against MBL and ESBL Co-Producing Gram-Negative Clinical Isolates: Possible Options for the Treatment of Complicated Infections. <i>Antibiotics</i> 2021, <i>10</i>, 1341

Antimicrobial Activity of Aztreonam in Combination with Old and New β-Lactamase Inhibitors against MBL and ESBL Co-Producing Gram-Negative Clinical Isolates: Possible Options for the Treatment of Complicated Infections

Determination of the capsular polysaccharide structure of the Klebsiella pneumoniae ST512 representative strain KPB-1 and assignments of the glycosyltransferases functions

Emerging Insights on the Interaction Between Anticancer and Immunosuppressant Drugs and Intestinal Microbiota in Pediatric Patients

Collaborators (8)

Claudia Mauri

M. Cristina Martins

Gianluca Morroni

Gianluca Turco

Gianfranco Sanson

lory saveria croce'

Mauro Giuffrè

Roberto Luzzati

Make your next move.

CRISTINA LAGATOLLA

Research Interests

Explore related searches

Contact this professor

Articles (7)

Electrospun Collagen-Coated Nanofiber Membranes Functionalized with Silver Nanoparticles for Advanced Wound Healing Applications

Vascular Graft Impregnation with a Fosfomycin/Oritavancin Combination to Prevent Early Infection

Aspirin and Infection: A Narrative Review

Correction: Morroni et al. Antimicrobial Activity of Aztreonam in Combination with Old and New &beta;-Lactamase Inhibitors against MBL and ESBL Co-Producing Gram-Negative Clinical Isolates: Possible Options for the Treatment of Complicated Infections. <i>Antibiotics</i> 2021, <i>10</i>, 1341

Antimicrobial Activity of Aztreonam in Combination with Old and New β-Lactamase Inhibitors against MBL and ESBL Co-Producing Gram-Negative Clinical Isolates: Possible Options for the Treatment of Complicated Infections

Determination of the capsular polysaccharide structure of the Klebsiella pneumoniae ST512 representative strain KPB-1 and assignments of the glycosyltransferases functions

Emerging Insights on the Interaction Between Anticancer and Immunosuppressant Drugs and Intestinal Microbiota in Pediatric Patients

Collaborators (8)

Claudia Mauri

M. Cristina Martins

Gianluca Morroni

Gianluca Turco

Gianfranco Sanson

lory saveria croce'

Mauro Giuffrè

Roberto Luzzati

Make your next move.

Correction: Morroni et al. Antimicrobial Activity of Aztreonam in Combination with Old and New β-Lactamase Inhibitors against MBL and ESBL Co-Producing Gram-Negative Clinical Isolates: Possible Options for the Treatment of Complicated Infections. <i>Antibiotics</i> 2021, <i>10</i>, 1341